Atea Pharmaceuticalsinc Stock Market Value
| AVIR Stock | USD 3.70 0.03 0.80% |
| Symbol | Atea |
Atea PharmaceuticalsInc Price To Book Ratio
Is Atea PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atea PharmaceuticalsI. If investors know Atea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atea PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.641 | Earnings Share (1.63) | Revenue Per Share 2.31 | Quarterly Revenue Growth 2.952 | Return On Assets (0.12) |
The market value of Atea PharmaceuticalsInc is measured differently than its book value, which is the value of Atea that is recorded on the company's balance sheet. Investors also form their own opinion of Atea PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Atea PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atea PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Atea PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atea PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Atea PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atea PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Atea PharmaceuticalsI 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Atea PharmaceuticalsI's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Atea PharmaceuticalsI.
| 03/26/2024 |
| 04/25/2024 |
If you would invest 0.00 in Atea PharmaceuticalsI on March 26, 2024 and sell it all today you would earn a total of 0.00 from holding Atea PharmaceuticalsInc or generate 0.0% return on investment in Atea PharmaceuticalsI over 30 days. Atea PharmaceuticalsI is related to or competes with Immix Biopharma, Cns Pharmaceuticals, Hepion Pharmaceuticals, AVROBIO, Enveric Biosciences, Elevation Oncology, and Ocean Biomedical. Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commerci... More
Atea PharmaceuticalsI Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Atea PharmaceuticalsI's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Atea PharmaceuticalsInc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.06 | |||
| Information Ratio | 0.0058 | |||
| Maximum Drawdown | 14.77 | |||
| Value At Risk | (5.01) | |||
| Potential Upside | 4.73 |
Atea PharmaceuticalsI Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Atea PharmaceuticalsI's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Atea PharmaceuticalsI's standard deviation. In reality, there are many statistical measures that can use Atea PharmaceuticalsI historical prices to predict the future Atea PharmaceuticalsI's volatility.| Risk Adjusted Performance | 0.031 | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.32) | |||
| Sortino Ratio | 0.0058 | |||
| Treynor Ratio | 0.0579 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Atea PharmaceuticalsI's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Atea PharmaceuticalsInc Backtested Returns
Atea PharmaceuticalsInc secures Sharpe Ratio (or Efficiency) of -0.0054, which signifies that the company had a -0.0054% return per unit of standard deviation over the last 3 months. Atea PharmaceuticalsInc exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Atea PharmaceuticalsI's risk adjusted performance of 0.031, and Mean Deviation of 2.41 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.78, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Atea PharmaceuticalsI will likely underperform. Atea PharmaceuticalsInc has an expected return of -0.016%. Please make sure to confirm Atea PharmaceuticalsInc maximum drawdown, and the relationship between the information ratio and expected short fall , to decide if Atea PharmaceuticalsInc performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.63 |
Good predictability
Atea PharmaceuticalsInc has good predictability. Overlapping area represents the amount of predictability between Atea PharmaceuticalsI time series from 26th of March 2024 to 10th of April 2024 and 10th of April 2024 to 25th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Atea PharmaceuticalsInc price movement. The serial correlation of 0.63 indicates that roughly 63.0% of current Atea PharmaceuticalsI price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.63 | |
| Spearman Rank Test | 0.65 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Atea PharmaceuticalsInc lagged returns against current returns
Autocorrelation, which is Atea PharmaceuticalsI stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Atea PharmaceuticalsI's stock expected returns. We can calculate the autocorrelation of Atea PharmaceuticalsI returns to help us make a trade decision. For example, suppose you find that Atea PharmaceuticalsI has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Atea PharmaceuticalsI regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Atea PharmaceuticalsI stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Atea PharmaceuticalsI stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Atea PharmaceuticalsI stock over time.
Current vs Lagged Prices |
| Timeline |
Atea PharmaceuticalsI Lagged Returns
When evaluating Atea PharmaceuticalsI's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Atea PharmaceuticalsI stock have on its future price. Atea PharmaceuticalsI autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Atea PharmaceuticalsI autocorrelation shows the relationship between Atea PharmaceuticalsI stock current value and its past values and can show if there is a momentum factor associated with investing in Atea PharmaceuticalsInc.
Regressed Prices |
| Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Atea PharmaceuticalsI in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Atea PharmaceuticalsI's short interest history, or implied volatility extrapolated from Atea PharmaceuticalsI options trading.
Pair Trading with Atea PharmaceuticalsI
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atea PharmaceuticalsI position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea PharmaceuticalsI will appreciate offsetting losses from the drop in the long position's value.Moving against Atea Stock
| 0.57 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.51 | CGC | Canopy Growth Corp Trending | PairCorr |
| 0.5 | ELYM | Eliem Therapeutics | PairCorr |
The ability to find closely correlated positions to Atea PharmaceuticalsI could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atea PharmaceuticalsI when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atea PharmaceuticalsI - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atea PharmaceuticalsInc to buy it.
The correlation of Atea PharmaceuticalsI is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atea PharmaceuticalsI moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atea PharmaceuticalsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atea PharmaceuticalsI can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Atea PharmaceuticalsI Correlation, Atea PharmaceuticalsI Volatility and Atea PharmaceuticalsI Alpha and Beta module to complement your research on Atea PharmaceuticalsI. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Atea Stock analysis
When running Atea PharmaceuticalsI's price analysis, check to measure Atea PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea PharmaceuticalsI is operating at the current time. Most of Atea PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Atea PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Atea PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
Atea PharmaceuticalsI technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.